These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 29556546)

  • 21. Gut Microbial Associations to Plasma Metabolites Linked to Cardiovascular Phenotypes and Risk.
    Kurilshikov A; van den Munckhof ICL; Chen L; Bonder MJ; Schraa K; Rutten JHW; Riksen NP; de Graaf J; Oosting M; Sanna S; Joosten LAB; van der Graaf M; Brand T; Koonen DPY; van Faassen M; ; Slagboom PE; Xavier RJ; Kuipers F; Hofker MH; Wijmenga C; Netea MG; Zhernakova A; Fu J
    Circ Res; 2019 Jun; 124(12):1808-1820. PubMed ID: 30971183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamic Bayesian Networks for Integrating Multi-omics Time Series Microbiome Data.
    Ruiz-Perez D; Lugo-Martinez J; Bourguignon N; Mathee K; Lerner B; Bar-Joseph Z; Narasimhan G
    mSystems; 2021 Mar; 6(2):. PubMed ID: 33785573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of Dietary Resistant Starch on the Human Gut Microbiome, Metaproteome, and Metabolome.
    Maier TV; Lucio M; Lee LH; VerBerkmoes NC; Brislawn CJ; Bernhardt J; Lamendella R; McDermott JE; Bergeron N; Heinzmann SS; Morton JT; González A; Ackermann G; Knight R; Riedel K; Krauss RM; Schmitt-Kopplin P; Jansson JK
    mBio; 2017 Oct; 8(5):. PubMed ID: 29042495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. VOLARE: visual analysis of disease-associated microbiome-immune system interplay.
    Siebert JC; Neff CP; Schneider JM; Regner EH; Ohri N; Kuhn KA; Palmer BE; Lozupone CA; Görg C
    BMC Bioinformatics; 2019 Aug; 20(1):432. PubMed ID: 31429723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcriptionally Active Lung Microbiome and Its Association with Bacterial Biomass and Host Inflammatory Status.
    Ren L; Zhang R; Rao J; Xiao Y; Zhang Z; Yang B; Cao D; Zhong H; Ning P; Shang Y; Li M; Gao Z; Wang J
    mSystems; 2018; 3(5):. PubMed ID: 30417108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The human gut microbiome: current knowledge, challenges, and future directions.
    Dave M; Higgins PD; Middha S; Rioux KP
    Transl Res; 2012 Oct; 160(4):246-57. PubMed ID: 22683238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of type 1 and type 2 diabetes risk by the intestinal microbiome.
    Paun A; Danska JS
    Pediatr Diabetes; 2016 Nov; 17(7):469-477. PubMed ID: 27484959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An introduction to microbiome analysis for human biology applications.
    Amato KR
    Am J Hum Biol; 2017 Jan; 29(1):. PubMed ID: 27762069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune recognition and response to the intestinal microbiome in type 1 diabetes.
    Paun A; Yau C; Danska JS
    J Autoimmun; 2016 Jul; 71():10-8. PubMed ID: 26908163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monitoring and Modulating Diet and Gut Microbes to Enhance Response and Reduce Toxicity to Cancer Treatment.
    Knisely A; Seo YD; Wargo JA; Chelvanambi M
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Gut Microbiota and Hematopoietic Stem Cell Transplantation: Challenges and Potentials.
    Noor F; Kaysen A; Wilmes P; Schneider JG
    J Innate Immun; 2019; 11(5):405-415. PubMed ID: 30286447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lifestyle alters GUT-bacteria function: Linking immune response and host.
    Jazayeri O; Daghighi SM; Rezaee F
    Best Pract Res Clin Gastroenterol; 2017 Dec; 31(6):625-635. PubMed ID: 29566905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microbiome and metabolome data integration provides insight into health and disease.
    Shaffer M; Armstrong AJS; Phelan VV; Reisdorph N; Lozupone CA
    Transl Res; 2017 Nov; 189():51-64. PubMed ID: 28764956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biomimetic Gut Model Systems for Development of Targeted Microbial Solutions for Enhancing Warfighter Health and Performance.
    Brinkac LM; Rahman N; Chua LL; Thomas S
    mSystems; 2020 Oct; 5(5):. PubMed ID: 33109750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional Genomics of Host-Microbiome Interactions in Humans.
    Luca F; Kupfer SS; Knights D; Khoruts A; Blekhman R
    Trends Genet; 2018 Jan; 34(1):30-40. PubMed ID: 29107345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential for Monitoring Gut Microbiota for Diagnosing Infections and Graft-versus-Host Disease in Cancer and Stem Cell Transplant Patients.
    Koh AY
    Clin Chem; 2017 Nov; 63(11):1685-1694. PubMed ID: 28720679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.
    Chen R; Wang J; Zhan R; Zhang L; Wang X
    J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Key Technologies for Progressing Discovery of Microbiome-Based Medicines.
    Young RB; Marcelino VR; Chonwerawong M; Gulliver EL; Forster SC
    Front Microbiol; 2021; 12():685935. PubMed ID: 34239510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. From Infection to the Microbiome: An Evolving Role of Microbes in Schizophrenia.
    Severance EG; Yolken RH
    Curr Top Behav Neurosci; 2020; 44():67-84. PubMed ID: 30847804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review article: the gut microbiome in inflammatory bowel disease-avenues for microbial management.
    McIlroy J; Ianiro G; Mukhopadhya I; Hansen R; Hold GL
    Aliment Pharmacol Ther; 2018 Jan; 47(1):26-42. PubMed ID: 29034981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.